Lung Cancer News

The Healio Editors have compiled a list of the most-read news in pulmonology posted in July.

This week, CHEST issues guidelines for low-dose CT screening for lung cancer; severe COVID-19 survivors experience pulmonary impairment; the FDA approves Prograf to prevent lung transplant rejection; and more.

Current smokers with early-stage lung cancer who quit smoking after their diagnosis had improved overall and progression-free survival rates, according to a prospective cohort study.

The American College of Chest Physicians released a new guideline and expert panel report that contains recommendations and updates the evidence base for the benefits, harms and implementation of low-dose CT screening for lung cancer.

National Comprehensive Cancer Network guidelines recommend all patients with advanced nonsquamous non-small cell lung cancer undergo biomarker testing.

Patients with asthma-COPD overlap have elevated risk for lung cancer compared with smokers and similar rates of lung cancer compared with those with COPD, but greater risk than patients with asthma alone, researchers reported.

Sukhmani K. Padda, MD, has been selected to direct thoracic medical oncology at Cedars-Sinai Cancer.

The FDA granted fast track designation to bemcentinib in combination with an anti-PD-L1 agent for treatment of patients with AXL-positive advanced or metastatic non-small cell lung cancer.

Patients with cancer who contracted COVID-19 had high risk for inpatient hospital admission and death, according to study results presented during the virtual ASCO Annual Meeting.

A randomized phase 3 study designed to evaluate sugemalimab as treatment of stage III non-small cell lung cancer met its primary endpoint, according to the agent’s manufacturer.